Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1998050550) HUMAN TRANSLOCATION ASSOCIATED PROTEIN
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/050550 International Application No.: PCT/US1998/009095
Publication Date: 12.11.1998 International Filing Date: 06.05.1998
IPC:
A61K 38/00 (2006.01) ,C07K 14/705 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
705
Receptors; Cell surface antigens; Cell surface determinants
Applicants:
INCYTE PHARMACEUTICALS, INC. [US/US]; 3174 Porter Drive Palo Alto, CA 94304, US (AllExceptUS)
HILLMAN, Jennifer, L. [US/US]; US (UsOnly)
CORLEY, Neil, C. [US/US]; US (UsOnly)
GOLI, Surya, K. [IN/US]; US (UsOnly)
Inventors:
HILLMAN, Jennifer, L.; US
CORLEY, Neil, C.; US
GOLI, Surya, K.; US
Agent:
BILLINGS, Lucy, J.; Incyte Pharmaceuticals, Inc. 3174 Porter Drive Palo Alto, CA 94304, US
Priority Data:
08/852,80907.05.1997US
Title (EN) HUMAN TRANSLOCATION ASSOCIATED PROTEIN
(FR) PROTEINE HUMAINE ASSOCIEE A LA TRANSLOCATION
Abstract:
(EN) The present invention provides a human translocation associated protein (Gp25L-H) and polynucleotides which identify and encode Gp25L-H. The invention also provides expression vectors, host cells, antibodies and antagonists. The invention also provides methods for the prevention and treatment of diseases associated with expression of Gp25L-H, as well as diagnostic assays.
(FR) L'invention concerne une protéine humaine associée à la translocation (Gp25L-H) et des polynucléotides qui identifient et codent la Gp25L-H en question. L'invention concerne aussi des vecteurs d'expression, des cellules hôtes, des anticorps et des antagonistes. Elle concerne enfin des procédés pour la prévention et le traitement des troubles associés à l'expression de cette Gp25L-H, et des épreuves diagnostiques.
Designated States: AT, AU, BR, CA, CH, CN, DE, DK, ES, FI, GB, IL, JP, KR, MX, NO, NZ, RU, SE, SG, US
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
AU1998073688